Brown Brothers Harriman & Co. Purchases 275 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Brown Brothers Harriman & Co. increased its position in Church & Dwight Co., Inc. (NYSE:CHD) by 41.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 943 shares of the company’s stock after buying an additional 275 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Church & Dwight were worth $99,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in CHD. Capital Performance Advisors LLP bought a new position in shares of Church & Dwight during the third quarter valued at $27,000. Ashton Thomas Securities LLC bought a new position in Church & Dwight during the 3rd quarter worth $28,000. Rothschild Investment LLC acquired a new position in Church & Dwight during the 2nd quarter worth about $31,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Church & Dwight in the 2nd quarter valued at about $33,000. Finally, Strategic Financial Concepts LLC acquired a new stake in shares of Church & Dwight in the second quarter valued at about $38,000. Institutional investors own 86.60% of the company’s stock.

Church & Dwight Stock Performance

CHD opened at $110.36 on Friday. Church & Dwight Co., Inc. has a 1-year low of $90.26 and a 1-year high of $113.50. The company has a market cap of $27.04 billion, a price-to-earnings ratio of 49.49, a PEG ratio of 4.04 and a beta of 0.55. The company’s fifty day moving average price is $104.73 and its two-hundred day moving average price is $104.33. The company has a current ratio of 1.62, a quick ratio of 1.09 and a debt-to-equity ratio of 0.53.

Church & Dwight (NYSE:CHD) last posted its earnings results on Friday, November 1st. The company reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.68 by $0.11. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. The firm’s revenue was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.74 EPS. On average, analysts expect that Church & Dwight Co., Inc. will post 3.45 EPS for the current fiscal year.

Church & Dwight Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be given a dividend of $0.2838 per share. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date is Friday, November 15th. Church & Dwight’s payout ratio is currently 50.67%.

Analyst Ratings Changes

CHD has been the topic of several analyst reports. Truist Financial reduced their target price on Church & Dwight from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, August 5th. Evercore ISI reduced their price objective on shares of Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a research note on Monday, August 5th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Piper Sandler began coverage on shares of Church & Dwight in a research report on Tuesday, September 24th. They set an “overweight” rating and a $120.00 price target on the stock. Finally, TD Cowen lifted their price objective on Church & Dwight from $114.00 to $117.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $108.53.

Insider Buying and Selling

In other news, CEO Matthew Farrell sold 165,823 shares of Church & Dwight stock in a transaction on Monday, November 4th. The stock was sold at an average price of $103.03, for a total transaction of $17,084,743.69. Following the sale, the chief executive officer now directly owns 112,719 shares in the company, valued at $11,613,438.57. The trade was a 59.53 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Joseph James Longo sold 7,780 shares of the stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $112.44, for a total transaction of $874,783.20. Following the transaction, the chief accounting officer now owns 400 shares of the company’s stock, valued at approximately $44,976. The trade was a 95.11 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 543,513 shares of company stock worth $56,795,253. 2.00% of the stock is owned by insiders.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.